RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Altitude Life Science Ventures
A

Altitude Life Science Ventures portfolio

Altitude Life Science Ventures has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $54.4M.
Latest deal: Ansa Biotechnologies · Oct 1, 2025.
About this page

Its most recent investment on record is Ansa Biotechnologies's $54.4M Series B+ round in October 2025, alongside Fall Line Capital, Cerberus Ventures, Blue Water Life Science Advisors and 2 others. That company is in Health and bio.

What Altitude Life Science Ventures invests in

How Altitude Life Science Ventures invests

StageDealsCapital in rounds
Series B+ 1 100%$54.4M

Altitude Life Science Ventures portfolio companies

CompanyRound with Altitude Life Science VenturesTotal raisedLatest raise
AAnsa Biotechnologies
Health and bio
Series B+ · $54.4M$122.4MOct 1, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Altitude Life Science Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Altitude Life Science Ventures, which is a subset of its real portfolio. API: /api/v1/investors/altitude-life-science-ventures (get a free API key). More: the most active VC firms and new venture capital funds.